Home Cart 0 Sign in  

[ CAS No. 668270-12-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 668270-12-0
Chemical Structure| 668270-12-0
Structure of 668270-12-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 668270-12-0 ]

Related Doc. of [ 668270-12-0 ]

Alternatived Products of [ 668270-12-0 ]

Product Details of [ 668270-12-0 ]

CAS No. :668270-12-0 MDL No. :MFCD14635356
Formula : C25H28N8O2 Boiling Point : -
Linear Structure Formula :- InChI Key :LTXREWYXXSTFRX-QGZVFWFLSA-N
M.W : 472.54 Pubchem ID :10096344
Synonyms :
BI 1356;GSK2118436;Linagliptin. trade names Tradjenta and Trajenta
Chemical Name :(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

Calculated chemistry of [ 668270-12-0 ]

Physicochemical Properties

Num. heavy atoms : 35
Num. arom. heavy atoms : 19
Fraction Csp3 : 0.4
Num. rotatable bonds : 4
Num. H-bond acceptors : 6.0
Num. H-bond donors : 1.0
Molar Refractivity : 139.33
TPSA : 116.86 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -7.83 cm/s

Lipophilicity

Log Po/w (iLOGP) : 4.03
Log Po/w (XLOGP3) : 1.91
Log Po/w (WLOGP) : 0.85
Log Po/w (MLOGP) : 1.8
Log Po/w (SILICOS-IT) : 1.56
Consensus Log Po/w : 2.03

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.11
Solubility : 0.0366 mg/ml ; 0.0000775 mol/l
Class : Moderately soluble
Log S (Ali) : -3.99
Solubility : 0.0487 mg/ml ; 0.000103 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.99
Solubility : 0.00479 mg/ml ; 0.0000101 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.4

Safety of [ 668270-12-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 668270-12-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 668270-12-0 ]

[ 668270-12-0 ] Synthesis Path-Downstream   1~36

  • 1
  • [ 668273-75-4 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
99.2% Stage #1: 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine With hydrogenchloride In dichloromethane; water at 20℃; for 3h; Stage #2: With hydrogenchloride In ethanol; water at 35℃; for 2h; 2 1) To 20 g of the compound of formula II, dichloromethane (200 ml) was added to dissolve the reaction,5 mol / L hydrochloric acid (28 ml) was added dropwise at a rate of 20 mL / min at room temperature,The reaction was precipitated and the reaction was complete for about 3 hours. The filter cake was washed once with dichloromethane (50 ml)Suction to dry, available intermediates I,Use Pharmacopoeia 2010 Edition Appendix VIII A Chloride Test Method for Trihydrochloride,Purity 99.9%.2) To the above-mentioned intermediate I was added ethanol (200 ml)Then add 6mol / L hydrochloric acid (29ml)Reaction at 35 ° C for 2 hours,After the reaction was completed, 30% sodium hydroxide was slowly added dropwise to the reaction solution to adjust ρH- = 12,Decompression concentrated dry,Add dichloromethane (200ml) extraction,Saturated brine (50 ml)The organic phase was dried over sodium sulfate, filtered,Concentrated under reduced pressureThe crude crude of linagliptin was 16.2 g, the yield was 98.1%. Take 15.0g linagliptin crude,To this was added ethanol (75 ml)Heated to reflux,Diethyl ether (375 ml) was added under reflux and then quenchedThen cooled to room temperature,The flocculent solid was gradually precipitated, filtered and dried under reduced pressure to give 14.9 g, yield 99.2% and purity 99.9%.
96.8% With methanol; water Reflux; Inert atmosphere; 50 Example 50 Add 31.71g to the reaction flask8-[(3R)-3-tert-butoxycarbonylamino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[ (4-Methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione,100ml of methanol, 60ml of water, stirring under a nitrogen environment, heating to reflux for 6-9 hours and then cooling to room temperature, a solid precipitated. After filtering, the filter cake is washed with a small amount of methanol, and linagliptin is obtained after drying. The molar yield is 96.8%, the purity is 99.9%, and the maximum single impurities is 0.01%.
96.8% With methanol; water Inert atmosphere; Reflux; 50 Example 50 Add 31.71g 8-[(3R)-3-tert-butoxycarbonylamino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione into the reaction flask,100ml of methanol, 60ml of water, stirring under a nitrogen environment, heating to reflux for 6-9 hours and then cooling to room temperature, a solid precipitated. After filtering, the filter cake is washed with a small amount of methanol, and linagliptin is obtained after drying. The molar yield is 96.8%, the purity is 99.9%, and the maximum single impurities is 0.01%.
92.8% With methanol; water Inert atmosphere; Reflux; 1.4 (4) Synthesis of linagliptin After deprotection of intermediate (g)The final product of glibenclamide.Steps:Into a 5 L reaction flask was charged 792.7 g of intermediate (g)2.4 L of methanol,1.5 L of water,After substitution with nitrogen three times,System confined,Turn on agitation,Heated to reflux.12 ~ 18h after the end of the reaction.Cooled to room temperature,Precipitation of solid.filter,The filter cake was washed with a small amount of methanol,The product was dried to give 586.5 g.The yield was 92.8%Purity 99.6%.
92.8% With methanol; water Reflux; Inert atmosphere; 1.4 (4) Synthesis of linagliptin After deprotection of the intermediate (g), the final product, linagliptin, is obtained. Steps: Into a 5 L reaction vessel, 792.7 g of intermediate (g), 2.4 L of methanol and 1.5 L of water were added and replaced with nitrogen three times, closed system, turn on agitation, heated to reflux. 12 ~ 18h after the end of the reaction. Cooled to room temperature, precipitation of solid. Filtered, the filter cake was washed with a small amount of methanol, the product was dried to give 586.5 g. The yield was 92.8% and the purity was 99.6%.
92.8% With methanol; water Inert atmosphere; Reflux; 1.4 (4) Synthesis of linagliptin After deprotection of intermediate (g)The final product of glibenclamide.Steps:Into a 5 L reaction flask was charged 792.7 g of intermediate (g)2.4 L of methanol,1.5 L of water,After substitution with nitrogen three times,System confined,Turn on agitation,Heated to reflux.12 ~ 18h after the end of the reaction.Cooled to room temperature,Precipitation of solid.filter,The filter cake was washed with a small amount of methanol,The product was dried to give 586.5 g.The yield was 92.8%Purity 99.6%.
91% With trifluoroacetic acid In dichloromethane at 20℃; for 1h;
91% With trifluoroacetic acid In dichloromethane at 5 - 20℃; for 5h; 7 7. Preparation of linagliptin Into a 1L four-neck reaction flask, compound formula VII (30.0g, 52.4mmol) and CH2Cl2 (200mL) were added. After the system was stirred, the ice-salt bath was cooled to 5 ° C. Then, a solution of TFA (75 mL) in CH2CI2 (100 mL) was slowly added dropwise to the system. After the dropwise addition, the system was naturally warmed to room temperature and reacted for 5h. Then add CH2CI2 (100mL) and H2O (300mL) to the system. After the system was stirred for 30min, the ice salt bath was cooled to 0 ° C. K2CO3 was slowly added to the system to adjust the pH value of the aqueous phase of the system to 9-10, and the organic phase was separated. The organic phase was washed twice with H20 (2X 150 mL). The organic phase solvent was removed under reduced pressure, and then heptane (500 mL) was added to the residue and stirred vigorously for 10 h. A large amount of solid was generated in the system. Filter by Büchner funnel, filter cake is blown to dry at 30C, light yellow Solid (linagliptin) (22.5g, 91%).
90% With trifluoroacetic acid In dichloromethane at 0 - 30℃; for 12h; 8 Example 8: Compound D was added to 400 ml of DCM and dissolved by stirring.At 0-10 ° C, 180 ml of TFA was added dropwise, and after the addition was completed, the temperature was raised to 20-30 ° C for 12 h, and the reaction was completed by TLC.Post-treatment: control the temperature 0-10 ° C, add concentrated ammonia water, adjust PH = 8.The layers were separated and the aqueous layer was extracted with 200 ml*2DCM.The oil was evaporated to dryness under reduced pressure, and then 50 ml of anhydrous ethanol was evaporated.Add 200 ml of absolute ethanol again, stir at 0-10 °C for 2 h.After suction filtration, the filter cake was rinsed with 50 ml of absolute ethanol to obtain 69 g of linagliptin, the yield was 90%, and the HPLC purity was 99.5%.
88% Stage #1: 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine With trifluoroacetic acid In dichloromethane at 20℃; Inert atmosphere; Stage #2: With water In 1,2-dichloro-ethane 24.I Process I Under nitrogen protection, 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-tert-butoxycarbonylaminopiperidin-1-yl)xanthine (5.0 g, 0.0087 mol) was added to 50 mL of dichloromethane, and stirred for dissolution. Trifluoroacetic acid (20 mL) was slowly added, and stirred at room temperature for 1-2 hours. 5 mL of water was added to the reaction mixture, and the organic phase was separated. The aqueous phase was washed with dichloromethane. The organic phase was combined, and washed triply with saturated sodium chloride solution. The dichloromethane solution was concentrated to give a crude 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-aminopiperidin-1-yl)xanthine. (0226) The above crude 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino piperidin-1-yl)xanthine was dissolved in 20 times volume of methanol, added with activated carbon (10 to 25% by weight), and heated to reflux for 1 hour. The activated carbon was removed by hot filtration, and the filtrate was concentrated to obtain a residue. A mixed solvent of methylene chloride:methyl t-butyl ether=1:10 (v/v) was added to the concentrated residue, and the obtained mixture was stirred for 1 hour and filtered to obtain a filter cake, which was dried at 45° C. in a drying oven to give 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)aminopiperidin-1-yl)xanthine (Compound I) with an optical purity of 100%. (0227) Yield: 3.61 g (88% of theoretical value) (0228) MS: [M+H]+=473.3
87.2% With trifluoroacetic acid In dichloromethane at 10 - 20℃; for 5h; 1 (1- [(4- methyl - quinazolin-2-yl) methyl] -3-methyl-7- (2-butyn-1-yl) -8 - [(R) -3- (t-butoxycarbonyl amino) -Piperidin-1-yl] -2,3,6,7-tetrahydro-2,6-dione --1H- purine)17.7g, 91.8% yield, 99.6% purity.Intermediate E (15g, 26.2mmol) was dissolved in 150ml of methylene chloride, cooled to 10 , dropwise 37.5mlTrifluoroacetic acid, dropwise was completed, the reaction for 5 hours at room temperature, was added dropwise 20% mass percentage of aqueous potassium carbonate solution to pH = 10 ~ 11, the organic layer was washed with water to pH = 6 ~ 7, dried over anhydrous sodium sulfate, filtered, and the organic layer evaporated to dryness,With ethanol and methyl tert-butyl ether to obtain crystals linagliptin 10.8g, 87.2% yield, 99.9% purity.
87.3% With formic acid; trifluoroacetic acid at 10 - 20℃; 1 Embodiment 1: [(3R) -3 - amino -1 - piperidinyl] -7 - (2 - ethyl-acetylene base) - 3, 7 - dihydro -3 - methyl -1 - [(4 - methyl -2 - pyridinyloxy) methyl] - 1H - purine - 2, 6 - dione (advantage Geleg sandbank) preparation of In the four neck bottles, taking intermediate II (100g, 1eq), adding formic acid (80.4g, 10eq), 10 - 20 °C adds by drops three fluorine acetic acid under (99.7g, 5eq), dropped 10 - 20 °C reaction 2 - 3 hours, TLC display of reaction, the reaction liquid concentrated steam 200 - 300 ml carboxylic acid, water (2.0L) in, adding dichloromethane 1L, adding NaOH solution (a concentration of 10 mol/L, referred to as 10N) adjusted to pH 9 - 10, separating the organic phase, dichloromethane again 2 time, combined with the organic phase, washed 1 time, saturated salt wash 1 time, dried with anhydrous sodium sulfate, concentrated, toluene (600 ml) re-crystallization, crystallization overnight at room temperature, filtered, 90 °C drying by blowing 2h, shall 72g advantage Geleg sandbank solid, yield 87.3%. Through test, HPLC purity _AOMARKENCODEGTX0AO _ 99.5%, ee % _AOMARKENCODEGTX0AO _ 99.5%, trifluoro acetylation impurity (type 2) _AOMARKENCODELTX0AO _ 0.05%
87.21% With trifluoroacetic acid In dichloromethane at 10℃; for 3h; 1.2; 2-7; 1-4 2) Preparation of linagliptin At room temperature, compound D (50.00 g, 87.3 mmol) was added to the reaction flask,Add 500 ml of dichloromethane and stir to dissolve, lower the temperature to below 10 ° C, and slowly add 125 ml of trifluoroacetic acid dropwise. After the dropwise addition, the reaction is performed for 3 hours.Post-treatment: Add 600ml of purified water to another reaction bottle, add sodium hydroxide (67.00g, 1675.0mmol), stir and dissolve to obtain a sodium hydroxide solution, lower the temperature to below 5 , and cool the reaction liquid in the reaction bottle When the temperature is below 10 , slowly add dropwise to the sodium hydroxide solution to control the temperature below 15 . After the dropwise addition, the solution pH = 9 10, stir for 15min, let stand for separation, the organic layer is extracted with water 250g * 2, the pH of the water layer = 7-8, the aqueous layer was extracted with 150 ml of dichloromethane * 2.The organic layers were combined, dried over anhydrous sodium sulfate, 2.5 g of activated carbon was added, stirred for 3 hours, filtered and concentrated to dryness to obtain crude E.To the crude product of E was added 200ml of absolute ethanol, and the temperature was raised to 80-85 ° C and stirred and dissolved.Slowly lower the temperature to 30 , keep warm and stir for 3 hours, slowly add 200ml of methyl tert-butyl ether. After the addition is completed, keep stirring at 30 for 2 hours, slowly cool to 15-20 and filter with methyl tert-butyl ether 140ml rinse.Drain until there is no filter drop.After drying, a white solid E (35.98 g, 76.1 mmol) was obtained with a yield of 87.21% and a purity of 99.992%.
82% With trifluoroacetic acid In dichloromethane at 5 - 25℃; for 4h; Large scale; 1.3 Li Gelitinepreparation: The reaction vessel was charged with 42 kg of dichloromethane,Trifluoroacetic acid 24 kg,Stir and cool to 5 ° C,Another 50L drop cans by adding methylene chloride 42kg,Intermediate II5.3kg stirred and dissolved,The solution was slowly added dropwise to the above reaction vessel,Keep the system temperature does not exceed 10 ,About 1hr drops finished,Heated to 25 temperature stirring 3hr,Detection of raw material intermediates II residues no more than 0.5% stop,The reaction solution was added to ice water to quench,Static sub-water phase,The organic phase was extracted three times with 25 kg of purified water,Consolidate the aqueous phase,Plus tetrahydrofuran 30kg,Temperature control at 50 plus 20% aqueous solution of sodium hydroxide 1.6Kg,Stir for 1 hr,Plus toluene 50kg stirring stratification,Organic addition of purified water 10kg washed 1 times,The tetrahydrofuran was distilled off under reduced pressure,10 kg of methyl tert-butyl ether was added,Cooling to 5 ° C stirring crystallization 2hr,filter,Methyl tert-butyl ether 2kg leaching to get crude,Crude plus anhydrous ethanol 20Kg,Stir to warm up to dissolve,Add activated carbon 0.5Kg, stirring and decolorizing for 30 minutes, precision filtration to the clean area crystallization kettle, slowly cooled to 5 , insulation crystallization 2hr filtration, filter cake with methyl tert-butyl ether 3kg washed in light yellow solid, wet The product is dried under reduced pressureDry weight loss does not exceed 0.5%A pale yellow dry product was used in the presence of 3.58 kg of the product, the yield was 82% and the purity was 99.87%.
79% With trifluoroacetic acid In dichloromethane at 1 - 15℃; for 20h; 3 Preparation of Linagliptin (Formula I) tert-Butyloxycarbonyl protected intermediate (Formula II; 35 g; prepared according to the process of Working Example 2 and dichloromethane (525 mL) were added into a reaction vessel at ambient temperature. The moisture content was adjusted to less than 0.1% by azeotropically distilling dichloromethane from the reaction mixture. The reaction mixture was cooled to 1°C, and trifluroacetic acid (139.6 g) was added slowly into the reaction mixture at 1°C to 4°C. The reaction mixture was stirred at 10°C to 15 °C for 20 hours. Progress of the reaction was monitored by HPLC. The reaction mixture was cooled to 2°C, and aqueous sodium hydroxide solution (56 g in 560 mL water) was slowly added at 2°C to 13°C. The reaction mixture was stirred at 26°C to 28°C for 4 hours followed by layer separation. The organic layer was washed with water (2 x 175 mL). Activated carbon (3.5g) was added to the organic layer, and the contents were stirred for 30 minutes at 27°C to 28°C. The contents were filtered through a Hyflo bed and washed with dichloromethane (2 x 35 mL). The organic layer was concentrated at 30°C under reduced pressure. Iso-propanol (105 mL) was added, and the contents were stirred at about 28°C for 2 hours and 30 minutes. The contents were filtered, washed with iso-propanol (35 mL), and dried under reduced pressure at 60°C to 65°C for 14 hours to obtain linagliptin. Yield: 79% HPLC Purity: 99.83%
70% Stage #1: 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine With hydrogenchloride In methanol; water for 4h; Reflux; Stage #2: With sodium hydroxide In methanol; water for 5h; Reflux; 1A; 1B Methanol (8.6 mL) was added to compound 4 (3.3 g, 5.7 mmol) and dissolved under heating under reflux, and then concentrated hydrochloric acid (concentration 37% (w/v))/methanol (1/3). (2.9 mL) was added, and the mixture was stirred at the same temperature for 4 hours (water content in the reaction was 3.9%). After the reaction was completed, deionized water (10 mL) was added, and methanol was distilled off under reduced pressure. Subsequently, extraction with ethyl acetate/deionized water was performed, and the aqueous layer was collected.[0064]Next, methanol (10 mL) and aqueous sodium hydroxide solution (6.0 mol/L, 8.1 mL) were sequentially added to the recovered aqueous layer to make it basic conditions, and then the mixture was stirred under heating under reflux for 5 hours. After adding sodium hydroxide, it was confirmed by pH test paper that the pH was 11 or more. After completion of the reaction, extraction with ethyl acetate/deionized water was performed, and the organic layer was collected.; As a result of HPLC analysis of the liquid, the impurity 1 was 0.101% and the impurity 2 was below the detection limit in the area area (%) of the compound 1, and the formation of the impurities 1 and 2 was certainly suppressed sufficiently. It became clear that there is.[0066]After the solvent was distilled off under reduced pressure, ethanol (11 mL) was added to the residue, and the mixture was stirred at 80°C. After the residue was completely dissolved, the temperature of the solution was lowered to 40° C. to precipitate crystals. The precipitated crystals were collected to obtain compound 1 (1.9 g, 4.0 mmol, 70%). The HPLC purity of compound 1 in the obtained crystals was 99.6%.
44% With trifluoroacetic acid In dichloromethane at 0 - 25℃; for 24h; Inert atmosphere; 1 Synthesis of Linagliptin from tert-butyl (R)-(l-(7-(but-2-yn-l-yl)-3-methyl-l-((4- methylquinazolin-2-yl)methyl)-2, 6-dioxo-2,3, 6, 7-tetrahydro-lH-purin-8-yl)piperidin-3- yl)carbamate (BOC-protected Linagliptin) Under inert atmosphere, 20 g (34.5 mmol) of (R)-l-(4-methyl-quinazolin-2- ylmethyl)-7-(but-2-ynyl)-8-(3 -tert-butoxycarbonylamino-piperidin- 1 -yl)-xanthine and (0103) 140 ml of methylene chloride are charged in a round bottom flask. 26.5 ml (345 mmol) of trifluoroacetic acid are slowly added at 0-5°C. The temperature is raised to 20-25°C and the mixture is kept under stirring, at the same temperature, for 24 hours. The mixture is cooled to 0-5°C and 200 ml of water are added. After phase separation, to the aqueous phase, maintaining the temperature at 5- 10°C, 100 ml of methylene chloride and 27 ml of an aqueous solution of 30% sodium hydroxide are then added (up to a pH of about 10). After separation of the aqueous phase, the organic phase is concentrated under vacuum. To the obtained residue, 83 ml of ethanol are added and the mixture is heated to reflux. The solution is cooled to 20-25°C, and 83 ml of methyl-t-butyl ether are added to the obtained suspension. The mixture is kept under stirring at 20-25°C for 1 h, then it is cooled at 0-5°C for 2 h. The solid is filtered, washed with 33 ml of methyl-t-butyl ether at 0-5°C and dried under vacuum at 45°C for 16 h to give 7 g of Linagliptin (I) (yield 44% HPLC purity 99.4%).
69 g With trifluoroacetic acid In dichloromethane; water at 20℃; for 3h; 11 Preparation of Linagliptin Form VIII Example 11 Preparation of Linagliptin Form VIII 1-[(4-Methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine (80 g, 0.14 mol) was mixed with dichloromethane (1.6 l, 20V), and trifluoroacetic acid (400 ml, 5V) to obtain a brown solution. The solution was stirred at room temperature for 3h. Then, water (400m1, 5V) was added, and the pH was adjusted to 8 with NH4OH 25%. The organic phase was then separated, and concentrated to dryness to provide a yellow solid (92 g). The yellow solid was then mixed with ethanol (400 ml) at room temperature. The resulting brown solution turned into an off-white suspension after 5-10 min. The suspension was stirred for 1.5 h, and then filtered to provide a wet solid (143 g). The wet solid was dried for 15 h at 60° C. under vacuum to provide 8-[3(R)-Aminopiperidin-1-yl]-7-(2-butynyl)-3-methyl-1-(4-methylquinazolin-2-ylmethyl)xanthine Form VIII (69 g).
With trifluoroacetic acid In dichloromethane at 25℃; for 2h; 7 EXAMPLE-7: Preparation of the amorphous form of linagliptin EXAMPLE-7: Preparation of the amorphous form of linagliptin 19 g compound (2) and 190 mL methylene dichloride were stirred at 25°C in round bottom flask. 70.3 g triflouro acetic acid and 95 mL methylene dichloride were added to the reaction mixture and stirred for 2 hours. 76 g aqueous potassium carbonate solution was cooled at 10°C and added to the reaction mixture. The reaction mixture was stirred for 30 min at 25°C and settled to separate the organic layer. The organic layer was treated with 3.68 g oxalic acid aqueous solution and stirred. 190 mL methylene dichloride was added to the separated aqueous layer and cooled to 20°C. 10% sodium hydroxide solution was added to the reaction mixture thereby to adjust the pH of 8-9. The separated organic layer was dried over sodium sulfate and filtered. The filtrate was distilled to remove methylene dichloride atmospherically at 40-45°C. 152 mL isopropanol was added to the residue and partially removed by distillation under vacuum at 50-55°C followed by cooling to 0-5°C. The reaction mixture was filtered and washed with methyl tert-butyl ether. The wet-cake was dissolved in 190 mL methylene dichloride and stirred for 30 min. The methylene dichloride was distilled under atmospheric pressure and degassed. The reaction mixture was cooled at ambient temperature and 76 mL methyl tert-butyl ether was added. The precipitated product was stirred for 30 min and filtered. The wet-cake was washed with methyl tert-butyl ether and dried under vacuum at 60°C for 6 hours to obtain amorphous linagliptin characterized by x-ray powder diffraction as depicted in FIGURE-2.
With trifluoroacetic acid In dichloromethane at 25 - 40℃; 6 Example 6: Preparation of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyI-7-(2- butyn-1-yI)-8-[3-(R)-amino-piperidin-1-yl]xanthine (Linagliptin) 500 ml of Dichloromethane and 100 g of l-[(4-methyl-quinazolin-2yl) methyl]-3- methyl-7-(2-butyn-l-yl)-8-[(R)-3-(tert-butyloxycarbonylamino)-piperidin-l-yl]- xanthine (0.1746 moles prepared in example-4) were added into 1 lit round bottom flask equipped with overhead stirrer, thermo pocket and dropping funnel at 25-30°C. To the reaction mixture was slowly added 200 ml of trifluoroacetic acid at 25-30 for about 30-60 min. The reaction mixture temperature was raised to 35-40°C and maintained for lhr. After completion of the reaction, in another flask 4000 ml DM water was charged and cooled to 10-15°C and slowly added to the above reaction. The reaction mixture temperature was raised to 25-30°C and maintained for 1 hr at same temperature; and the layers were separated. The aqueous layer was washed with 300 ml of dichloromethane and charged aqueous layer into RB flask and adjusted the pH 8.5-9.0 with 30% potassium carbonate solution. 800 ml of dichloromethane was charged and stirred for 15min and separated layers. The aqueous layer was again extracted with 300 ml of dichloromethane. The organic layers were combined and washed with brine solution. The solvent was distilled out completely U/V at 35-40°C and charged 350 ml of ethanol into the residue and the temperature was raised to 70- 75°C. The reaction mixture was maintained for 30 minutes at 75-80°C. The reaction mixture was slowly cooled to 25-35°C and stirred for 2-4 hrs. To the reaction mixture was charged 350 ml of methyl tertiary butyl ether, cooled to 0- 5°C and maintained 2hrs at same temperature. The solid was filtered and washed with 100 ml tertiary butyl ether. The wet material was dissolved in 600 ml of methanol and the methanol was evaporated using spray drier at below 50°C to obtain amorphous Linagliptin.
2.8 g With trifluoroacetic acid In dichloromethane at 20℃; for 3h; 8 (S)-8-(3-aminopiperidin-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-7-(prop-2-ynyl)-1H-purine-2,6(3H,7H)-dione (1i) General procedure: A mixture of 4b (88 mg, 0.2 mmol), (S)-3-(N-Boc-amino)piperidine (44 mg, 0.22 mmol) and K2CO3 (55 mg, 0.4 mmol) in DMF (6 mL) was stirred at 75 °C for 6 h. After cooling to r.t., the mixture was poured into water (12 mL) and extracted with DCM (3 * 10 mL). The combined organic layer was washed with saturated brine, dried over anhydrous Na2SO4, and concentrated. The crude product was purified by flash chromatography (petroleum ether/ethyl acetate, 1:1) to give the Boc precursor of 1i as a colorless syrup (80 mg, 72%), which was dissolved in DCM (2 mL), and TFA (390 μL) was added. The solution was stirred at room temperature for 3 h and then poured into ice-cold water (4 mL). The organic phase was separated, and the aqueous phase was basified with K2CO3 and extracted with DCM (2 * 10 mL). The organic layers were combined and washed with saturated brine, dried over anhydrous Na2SO4, and concentrated. The crude product was purified by flash chromatography (DCM/MeOH/TEA, 100:0.5:0.5) to give pure 1i as a white solid (51 mg, 85%).
23 g With trifluoroacetic acid In dichloromethane at 15 - 30℃; for 3h; 3 Example-3: Preparation of Linagliptin-Crude To the stirring solution of Boc-Linagliptin (35 gm) in dichloromethane (350 ml) at 15 °C was added trifluoroacetic acid (140g) slowly. After addition of trifluoro acetic acid, reaction mixture was heated to 25-30 °C and maintained for 3 hour. Reaction mixture was cooled to 5°C and water was added (200 ml) and adjust ed the pH of the reaction mixture 9-10 using ammonia solution (1 10 g). Dichloromethane layer Separated and concentrated. The reaction mass is treated with Isopropyl Acetate (490 ml) and its partial removal by distillation and cooling to 10-15°C yields crude Linagliptin (23 g). HPLC Purity: 98.43%
With trifluoroacetic acid In dichloromethane for 2h; 7 Example-7 Preparation of the Amorphous Form of Linagliptin 19 g compound (2) and 190 mL methylene dichloride were stirred at 25° C. in round bottom flask. 70.3 g triflouro acetic acid and 95 mL methylene dichloride were added to the reaction mixture and stirred for 2 hours. 76 g aqueous potassium carbonate solution was cooled at 10° C. and added to the reaction mixture. The reaction mixture was stirred for 30 min at 25° C. and settled to separate the organic layer. The organic layer was treated with 3.68 g oxalic acid aqueous solution and stirred. 190 mL methylene dichloride was added to the separated aqueous layer and cooled to 20° C. 10% sodium hydroxide solution was added to the reaction mixture thereby to adjust the pH of 8-9. The separated organic layer was dried over sodium sulfate and filtered. The filtrate was distilled to remove methylene dichloride atmospherically at 40-45° C. 152 mL isopropanol was added to the residue and partially removed by distillation under vacuum at 50-55° C. followed by cooling to 0-5° C. The reaction mixture was filtered and washed with methyl tert-butyl ether. The wet-cake was dissolved in 190 mL methylene dichloride and stirred for 30 min. The methylene dichloride was distilled under atmospheric pressure and degassed. The reaction mixture was cooled at ambient temperature and 76 mL methyl tert-butyl ether was added. The precipitated product was stirred for 30 min and filtered. The wet-cake was washed with methyl tert-butyl ether and dried under vacuum at 60° C. for 6 hours to obtain amorphous linagliptin characterized by x-ray powder diffraction as depicted in FIG. 2.
With trifluoroacetic acid In dichloromethane at 20℃; for 1.5h; 4 Example 4 Preparation of a new crystal form of linagliptin The 8-[(3R)-3-Boc-amino-1-piperidinyl]-7- (2-butynyl) -3, 7-dihydro-3-methyl -l - [( methyl-2-quinazolinyl) methyl] lH-purine-2,6-dione 60mL of dichloromethane was added 6g, 24. 3g of trifluoroacetic acid was added, the reaction stirred for 1. 5h at room temperature, the the reaction was added saturated aqueous sodium carbonate solution adjusted to pH 6-8, the organic phase was separated, the solvent was distilled off under reduced pressure to give an oil; 48ml of ethanol was added, heated to reflux to dissolve, was added 6mL of purified water, 60 ° C incubation with stirring to precipitate crystals, 120ml of isopropyl ether was added and stirred cooling to 20 ~ 30 ° C, filtered, and dried to give a white crystalline solid 3. 81g, yield 60.9%, purity 99.88%, water content 10.3%; was measured whose X-RPD spectrum consistent with 1, 2 which is consistent with the spectrum in FIG DSC-TGA, infrared absorption spectrum consistent with FIG.
With trifluoroacetic acid In dichloromethane at 20 - 25℃; 3 Example 3: Preparation of Linagliptin: To a 3000 mL glass vessel equipped with a stirrer, condenser and a thermometer probe were added Formula V (100.0 g, 0.17 mol) and MDC (600 mL, 6.0 vol), stirred to dissolveat 25±5 °C. The reaction mixture was cooled to 20 ±5 °C and TFA (200 mL, 2.0 vol) was added slowly and warmed to 25±5 °C and stirred for 6-8h. After completion of the reaction MDC (500 mL) was added and cooled the reaction mass to 3±3 °C, water (500 mL) prechilled to 5±3 °C was added and adjusted pH of the reaction mass to 9 to 11 using aq. Ammonia maintaining the reaction temperature at 5±3 °C. The reaction mass was warmed to 25±5 °C and stirred for 2 h. Layers were separated and MDC layer was preserved. The aqueous layer was re-extracted with MDC (300 mL). Combined MDC layers were treated with activated charcoal and stirred for 30 mm. The reaction mass was filtered over celitebed and washed the celite bed with MDC (200 mL). Filtrate as obtained was concentrated at a temperature below 45 °C up to 3.0 vol. with respect to weight of Formula V used as input. MTBE (1200 mL) was added dropwise at 25±5 °C to the partially concentrated product and stirred for 1 h. The reaction mass was further cooled to 5±3 °C and stirred for 2 h. The product as obtained was filtered off, washed with MTBE (200 mL) and suck dried.The product was dried at 45±5 °C under vacuum for lOh to obtain Linagliptin as a pale yellow solid. The product was kept at -5±5°C for 36 h, raised the temperature to 25±5°C and hold it for 4-5 h to obtain anhydrous crystalline form A/B of Linagliptin. The anhydrous crystalline form A/B of Linagliptin which is prepared as per Example-3 ischaracterized by DSC as represented in Figure-6.
4.99g With hydrogenchloride In methanol; dichloromethane at 45℃; for 4h; 8-9 Example 8: Preparation of linagliptin In 200 mL of a dichloromethane and methanol mixed solvent (the volume ratio of dichloromethane and methanol is 1: 4), 8.59 g (15 mmol) of Compound 7 was added, and 7.2 mL of concentrated hydrochloric acid was added dropwise. After the dropwise addition was completed, the mixture was stirred at 45 ° C. for 4 hours. TLC monitors the progress of the reaction. After the reaction is completed, cool to room temperature, remove the solution under reduced pressure, add 60 mL of distilled water, adjust the pH value of the system with a saturated sodium carbonate aqueous solution, and precipitate a solid. Crystallize at 0 ° C for 4 hours, filter, wash, and dry. 5.81 g (12.3 mmol) of crude liraritin was obtained with a yield of 82% and a purity of 97.7% by HPLC. Example 9: Refining of liraliptinDissolve 5.01 g of crude liraritin in 20 mL of ethanol under reflux, add methyl tert-butyl ether dropwise under stirring, stop solids in the system, stop heating, slowly cool to 0 ° C, crystallize for 2 hours, filter, After drying, 4.99 g of pure liraliptin was obtained, and the purity by HPLC was 99.9%.
With trifluoroacetic acid In dichloromethane at 40 - 45℃; 1 Example 1 Synthesis of Linagliptin Picolinate Salt 150 ml of methylene chloride (methylene chloride, MC) is added to 30 g of a compound of Formula 1 (hereinafter, LGT-1), and 65.7 g of trifluoroacetic acid (TFA) is slowly injected. The temperature inside the reactor is raised to 40 ° C to 45 ° C and stirred under reflux for 2 to 4 hours. After cooling to room temperature, 210 ml of H2O. Inject 60 ml of MC and stir at room temperature for 30 minutes. After stirring at room temperature, the aqueous layer is taken and stirred at room temperature for 30 minutes by injecting 300 ml of H 2 O into the separated organic layer. After stirring at room temperature, the aqueous layer is taken, and 300 ml of H 2 O is injected again into the separated organic layer and stirred at room temperature for 30 minutes. Thus, the repetition of the same process can raise the purity. Take water layer after stirring at room temperature and collect all separated water layers. The aqueous layer is washed twice with 60 ml of H 2 O under celite filtration. 300 ml of MC and 24 g of NaOH were added to the filtrate and stirred for 30 minutes. After stirring, the layers were separated to obtain an organic layer. Inject 150 ml of MC into the separated aqueous layer and stir for 30 minutes. After stirring, the layers were separated to obtain an organic layer. Collect all the organic layers and concentrate under reduced pressure. 300 ml of MeOH is added to a concentrated residue compound of Formula 2 (hereinafter referred to as Crude LGT in Scheme 1), and 6.45 g of picolinic acid is added thereto. The reaction solution was stirred under reflux for 30 minutes, cooled slowly to room temperature, stirred for 3 hours, and dehydrated. Washing twice with 30 ml of MeOH gave 21.84 g of novel linagliptin picolinate, a compound of formula 3 (LGT Picolinate in Scheme 1 below). (Yield 77.71%, Purity 98.82%)
68.6 g With zinc(II) chloride In dichloromethane at 30℃; for 5h; 1; 2 Example 1 The compound of formula II (100.0 g, 174.6 mmol) was added to dichloromethane (600 mL) with stirring, and ZnCl2 (95.2 g, 698.5 mmol) was added to the reaction solution. The temperature was raised to 30 ° C, and the reaction was stirred for 5 hours, and the reaction was monitored by TLC for completion. Cool to room temperature and filter. Add isopropyl alcohol (600 mL) to the filtrate, and a solid precipitates. Stir and filter at room temperature for 2 hours.The filter cake was dried under vacuum at 55 ± 5 ° C to obtain 68.6 g of ligagliptin, and the purity by HPLC (area normalization method) was 99.5%.
3.4 kg With trifluoroacetic acid In dichloromethane at 25℃; for 2h; Large scale; 1-3; 1 S4. Take another reactor, add 110kg of dichloromethane and 4.6kg of intermediate II obtained in step S3, add 25kg of trifluoroacetic acid to the above system at 25 ° C, and stir at 300rpm for 2h After the reaction is monitored by HPLC, 15% sodium carbonate is added dropwise, the pH is adjusted to 9.5, the layer is left standing, the organic layer is collected, acetic acid with a volume fraction of 5% is added dropwise, stirred for 30 minutes, and the water is collected standing Layer, add sodium carbonate with a mass fraction of 15%, adjust the pH to 9.5, let stand for layering, collect the organic layer, add 40 kg of dichloromethane to the water layer, stir and stand for layering, collect the organic layer, combine the organic layers , Wash with saturated sodium chloride solution 30kg, stand still and layer, collect the organic layer and concentrate to get the concentrated product; S5, take a new reaction kettle, add the concentrated product obtained in step S4 and 15.2kg of absolute ethanol to it, start Stir, heat and reflux until the solid is completely dissolved, add 0.1kg of activated carbon, filter while hot, then cool to 5 ° C, add 15kg of methyl tert-butyl ether dropwise, keep warm, stir at 450rpm for 1.0h, filter, filter cake With methyl tert-butyl ether 0.9kg washed once filter cake was collected, dried, to obtain.
153.5 g With trifluoroacetic acid at 30 - 40℃; for 3h; 1.4; 2-6 Step 4: Preparation of Linagliptin The above Boc-linagliptin was added to 400ml of trifluoroacetic acid, and the reaction was stirred at 30-40 °C. The reaction was detected by TLC. The reaction was completed in 3 hours, and the solvent of the reaction solution was evaporated to dryness. Add 300ml of water, 300ml of ethyl acetate, add dropwise 2mol/L hydrochloric acid pH 2 to 3, and separate the liquids. Add 100ml*2 water to the organic phase, extract and separate. Combine the water phases, add 300 ml of ethyl acetate, add dropwise a 1 mol/L sodium hydroxide solution pH 8-9, and separate the liquids. Add 100ml*2 ethyl acetate to the water phase, separate the liquids, combine the organic phases, dry with anhydrous sodium sulfate, and filter.The filtrate was evaporated to dryness under reduced pressure at 40 °C to obtain 153.5 g of off-white solid linagliptin. The total yield of the three-step reaction is 79.6%, and the HPLC purity is 99.96%
88 % Stage #1: 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine With hydrogenchloride In dichloromethane; water at -15℃; Stage #2: With tetrabutylammomium bromide; sodium hydroxide In water; toluene at 60 - 65℃;

Reference: [1]Current Patent Assignee: SICHUAN KELUN PHARMACEUTICAL COMPANY LIMITED - CN106554354, 2017, A Location in patent: Paragraph 0134-0137
[2]Current Patent Assignee: LUNAN PHARMACEUTICAL GROUP CO LTD - CN111574520, 2020, A Location in patent: Paragraph 0173-0175
[3]Current Patent Assignee: LUNAN PHARMACEUTICAL GROUP CO LTD - CN111574463, 2020, A Location in patent: Paragraph 0177-0178
[4]Current Patent Assignee: Chifeng Sailintai Pharmaceutical Co., Ltd.;Cui, Yujie;Zhang, Lihua;Zhao, Hongwei;Wang, Yanfeng;Ji, Liping;Sheng, Li;Wang, Jieting;Ma, Zheng - 2016 Location in patent: Paragraph 0053; 0054; 0055; 0056
[5]Current Patent Assignee: CHIFENG SALIONT PHARMACEUTICAL - CN105936634, 2016, A Location in patent: Paragraph 0123; 0124; 0125; 0126
[6]Current Patent Assignee: Chifeng Sailintai Pharmaceutical Co., Ltd.;Cui, Yujie;Zhang, Lihua;Zhao, Hongwei;Wang, Yanfeng;Ji, Liping;Sheng, Li;Wang, Jieting;Ma, Zheng - 2016 Location in patent: Paragraph 0053; 0054; 0055; 0056
[7]Eckhardt, Matthias; Langkopf, Elke; Mark, Michael; Tadayyon, Moh; Thomas, Leo; Nar, Herbert; Pfrengle, Waldemar; Guth, Brian; Lotz, Ralf; Sieger, Peter; Fuchs, Holger; Himmelsbach, Frank [Journal of Medicinal Chemistry, 2007, vol. 50, # 26, p. 6450 - 6453]
[8]Current Patent Assignee: NANJING JUNRUO BIOMEDICAL RES INSTITUTE; HAIMEN BAIKANG PHARMACEUTICAL; JIANGSU JUNRUO PHARMACEUTICAL - CN110872292, 2020, A Location in patent: Paragraph 0037-0038
[9]Current Patent Assignee: WEIHAI KAIMEIKE MEDICAL TECHNOLOGY DEV - CN104844602, 2018, B Location in patent: Paragraph 0045; 0046
[10]Current Patent Assignee: 2Y CHEM - US2015/274728, 2015, A1 Location in patent: Paragraph 0224-0228
[11]Current Patent Assignee: SHANGHAI WONDER PHARMACEUTICAL CO LTD - CN105622609, 2016, A Location in patent: Paragraph 0051
[12]Current Patent Assignee: SHANGHAI MODERN PHARMACEUTICAL CO., LTD.; CHINA NATIONAL PHARMACEUTICAL GROUP CORPORATION - CN106478629, 2017, A Location in patent: Paragraph 0022-0027
[13]Current Patent Assignee: GAN LEE PHARMACEUTICALS JIANGSU - CN110964013, 2020, A Location in patent: Paragraph 0033; 0041-0043; 0044-0065
[14]Current Patent Assignee: HEFEI YUANZHI PHARMACEUTICAL R D - CN106008508, 2016, A Location in patent: Paragraph 0016; 0023; 0024; 0025; 0031; 0032
[15]Current Patent Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED - WO2015/11609, 2015, A1 Location in patent: Page/Page column 13
[16]Current Patent Assignee: YAMASA CORPORATION - JP2020/70296, 2020, A Location in patent: Paragraph 0061-0067
[17]Current Patent Assignee: PERMIRA HOLDINGS LIMITED; CAMBREX PROFARMACO MILANO S R L - WO2019/219620, 2019, A1 Location in patent: Page/Page column 12
[18]Current Patent Assignee: TEVA PHARMACEUTICAL INDUSTRIES LTD. - US2013/123282, 2013, A1 Location in patent: Paragraph 0158
[19]Current Patent Assignee: ZYDUS LIFESCIENCES LTD - WO2013/171756, 2013, A1 Location in patent: Page/Page column 17
[20]Current Patent Assignee: VIATRIS INC - WO2014/97314, 2014, A1 Location in patent: Page/Page column 11-12
[21]Lai, Zeng-Wei; Li, Chunhong; Liu, Jun; Kong, Lingyi; Wen, Xiaoan; Sun, Hongbin [European Journal of Medicinal Chemistry, 2014, vol. 83, p. 547 - 560]
[22]Current Patent Assignee: WOCKHARDT LIMITED - WO2015/4599, 2015, A1 Location in patent: Page/Page column 19
[23]Current Patent Assignee: ZYDUS LIFESCIENCES LTD - US2015/51228, 2015, A1 Location in patent: Paragraph 0141
[24]Current Patent Assignee: QILU PHARMACEUTICAL GROUP CO LTD - CN105272982, 2016, A Location in patent: Paragraph 0044-0045
[25]Current Patent Assignee: BIOCON LIMITED - WO2019/64214, 2019, A1 Location in patent: Page/Page column 10; 11
[26]Current Patent Assignee: SHENZHEN SECOND PEOPLE`S HOSPITAL - CN110590780, 2019, A Location in patent: Paragraph 0052-0056
[27]Current Patent Assignee: KYONGBO PHARM - KR2019/124536, 2019, A Location in patent: Paragraph 0048-0051
[28]Current Patent Assignee: BEIJING RONGYING PHARMACEUTICAL TECH - CN110615790, 2019, A Location in patent: Paragraph 0004; 0008; 0009
[29]Current Patent Assignee: YANGTZE RIVER PHARMACEUTICAL GROUP CO LTD - CN110684026, 2020, A Location in patent: Paragraph 0040; 0045-0047; 0052-0054; 0059; 0061; 0066-0067
[30]Current Patent Assignee: SHANDONG YONGCHENG PHARMACY - CN112724140, 2021, A Location in patent: Paragraph 0041; 0048-0059
[31]Wang, Hailong; Chen, Kai; Lin, Biyue; Kou, Jingping; Li, Lijun; Wu, Shuming; Liao, Shouzhu; Sun, Guodong; Pu, Junwen; Yang, Hua; Wang, Zhongqing [Organic Process Research and Development, 2022, vol. 26, # 12, p. 3254 - 3264]
  • 2
  • [ 886588-63-2 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
87% With ethanolamine In toluene at 70 - 90℃; 10 Example 10: 40 g (0.066 mol) of intermediate D' was added to 400 ml of toluene and the mixture was warmed to dissolve between 80-90 °C.Then, 40 g (0.66 mol) of ethanolamine was added thereto while cooling to 70-80 °C.Warm to 80-90 ° C and stir for 3-4 h.After the TLC monitoring reaction was completed, the heating was stopped.
83.2% With ethanolamine In toluene at 75 - 85℃; for 2h;
83% Stage #1: (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione With ethanolamine In toluene at 75 - 85℃; for 2h; Inert atmosphere; Stage #2: With water In toluene at 75 - 80℃; 24.II Process II A solution of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8(3-(R)-phthalimidopiperidin-1-yl)xanthine (3.6 g, 0.006 mol) in 36 mL of toluene was heated to 80-85° C. under nitrogen protection, followed by addition of 3.6 g (0.06 mol) of ethanolamine at 75-80° C. The mixture was stirred at 80-85° C. for 2 hours, and the mixture became clear. The toluene layer was separated and collected. The ethanolamine layer was washed twice with toluene (each 20 mL). The combined toluene layer was washed twice with water (40 mL) at 75-80° C. Toluene solution was collected and concentrated under reduced pressure, and toluene was distilled off. Methyl tert-butyl ether (40 mL) was added to the concentrated residue at 40-50° C., and cooled to 0-5° C. After filtration, the filter cake was collected. The obtained solid was dissolved in 20 times volume of methanol, added with activated carbon (10 to 25% by weight), and heated to reflux for 1 hour. The activated carbon was removed by hot filtration. The filtrate was concentrated to obtain a residue. A mixed solvent of methylene chloride:methyl t-butyl ether=1:10 was added to the concentrated residue, and the obtained mixture was stirred for 1 hour, filtered to obtain a filter cake, which was dried at 45° C. in a drying oven to give 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-aminopiperidin-1-yl)xanthine (Compound I) with an optical purity of 100%. (0231) Yield: 2.35 g (83% of theoretical value) (0232) Specific optical rotation [α]25D=-20.1°, C=1, DMF (0233) MS: [M+H]+=473.3 (0234) 1H-NMR (400 MHz, DMSO): δ 1.19-1.31 (m, 1H), 1.57-1.69 (m, 1H), 1.77 (t, J=2.0 Hz, 3H), 1.75-1.83 (m, 1H), 1.84-1.92 (m, 1H), 2.75-2.88 (m, 2H), 2.89 (s, 3H), 2.97-3.06 (m, 1H), 3.36 (broad, s, 2H), 3.41 (s, 3H), 3.58-3.88 (m, 2H), 4.90 (s, 2H), 5.32 (s, 2H), 7.68 (dd, J=8.4, 6.8 Hz, 1H), 7.81 (d, J=8.3 Hz, 1H), 7.92 (dd, J=8.2 Hz, 1H), 8.25 (d, J=8.1 Hz, 1H). (0235) 13C-NMR (100 MHz, DMSO): δ 3.03, 21.53, 23.25, 29.40, 33.08, 35.47, 45.53, 47.23, 49.55, 57.46, 73.72, 81.12, 103.19, 122.47, 125.71, 127.12, 127.85, 134.05, 147.74, 149.03, 150.93, 153.23, 156.14, 160.97, 168.82.
83% With ethanolamine In toluene at 83℃; for 2.5h; Inert atmosphere; 2.1 Method 1 : In a 500 mL flask, 14 g of (R)-7-(but-2-yn-l-yl)-8-(3-(l,3-dioxoisoindolin-2- yl)piperidin- 1 -yl)-3 -methyl- 1 -((4-methylquinazolin-2-yl)methyl)-3 ,7-dihydro- 1 H-purine- 2,6-dione (23.2 mmol) and 140 mL of Toluene are charged at 20°C under inert atmosphere. After heating the suspension to 83°C in 30 min, 14 mL of Ethanolamine (232.3 mmol) are added dropwise. The solution is maintained at 83°C for 2 h. Ethanolamine phase is separated from the toluene phase. Ethanolamine is washed with Toluene (2 x 31 mL) at 20°C. The toluene phases are combined and washed with water (2 x 62 mL) at 83°C. 160 mL of toluene are distilled under vacuum and methyltertbutyl ether (31 mL) is added at 45°C allowing the product precipitation. The suspension is cooled to 0°C in 1 hour and filtered. The solid is washed with methyltertbutyl ether (31 mL) at 0°C. The wet product is dried under vacuum at 45 °C for 16 h (yield 83%; HPLC purity 95.6%).
81.9% Stage #1: (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione With ethanolamine In tetrahydrofuran; water at 55 - 65℃; for 3h; Stage #2: With sodium hydroxide In tetrahydrofuran; water

  • 3
  • [ 1770824-68-4 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
73% Stage #1: (R)-isopropyl 1-(7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8 yl)piperidin-3-ylcarbamate With hydrogenchloride; water at 65 - 70℃; for 7h; Stage #2: With sodium hydroxide In water at 20℃; for 0.166667h; 4 Example 4: Preparation of Linagliptin The carbamate of formula (IV), prepared according to Example 3 (400 mg, 0.72 mmols), is dissolved in 5 ml of 32% HCl in water. The reaction mixture is maintained under stirring at 65-70°C for 7 hours and then cooled to room temperature. The pH of the solution is brought to about 8-9 by treatment with 30% NaOH in water and the obtained suspension is stirred for 10 minutes and then filtered off. The solid is dissolved in 10 ml of AcOEt, the solution is filtered and the filtrate is evaporated under reduced pressure. 250 mg of Linagliptin are obtained with a yield of 73%.
73% Stage #1: (R)-isopropyl 1-(7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8 yl)piperidin-3-ylcarbamate With hydrogenchloride; water at 65 - 70℃; for 7h; Stage #2: With sodium hydroxide In water at 20℃; for 0.166667h; 4 Example 4Preparation of LinagliptinThe carbamate of formula (IV), prepared according to Example 3 (400 mg, 0.72 mmols), are dissolved in 5 ml of 32% HCl in water. The reaction mixture is maintained under stirring at 65-70° C. for 7 hours and then cooled to room temperature. The pH of the solution is brought to about 8-9 by treatment with 30% NaOH in water and the obtained suspension is stirred for 10 minutes and then filtered off. The solid is dissolved in 10 ml of AcOEt, the solution is filtered and the filtrate is evaporated under reduced pressure. 250 mg of Linagliptin are obtained with a yield of 73%.
0.23 g With water; potassium hydroxide In N,N-dimethyl acetamide at 0 - 50℃; for 5h; Inert atmosphere; 6 Synthesis of Linagliptin (R)-isopropyl 1 -(7-(but-2-inyl)-3-methyl-1 -((4-methylquinazolin-2-yl)methyl)- 2,6-dioxo-2,3,6,7-tetrahydro-1 /-/-purin-8-yl)piperidin-3-il carbamate (0.30 g, 0.55 mmol), dimethylacetamide (5ml) were charged into a reaction flask under inert atmosphere, the reaction mixture was brought to a temperature from 0°C to 5°C and under stirring, potassium hydroxide (0.032 g, 0.57 mmol) and water (3 ml) were charged. The temperature was brought to about 50°C and the reaction mixture was kept under such conditions for about 5 hours. At the end of the reaction demineralized water (5 ml) was added, the resultant solid was filtered and washed with demineralized water (1 x 5 ml) and dried in oven under vacuum at about 50°C to give 0.23 g of Linagliptin.
  • 4
  • [ CAS Unavailable ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
63% With water; sodium hydroxide In 1-methyl-pyrrolidin-2-one for 3h; 6 Example 6: Preparation of Linagliptin The thiocarbamate of formula (IV) (10 g, 14,3 mmols), prepared according to Example 5, is dissolved in 100 mL of N-methylpyrrolidone (NMP) and treated with a 30% NaOH solution (7.6 g, 57.0 mmols). The reaction mixture is stirred for 3 hours and then diluted with water and acidified by adding concentrated H2SO4. The mixture is extracted with hexane and brought to pH 9.5 by adding 30% NaOH and repeatedly extracted with dichloromethane. The dichloromethane phases are collected and washed with water and then dried over Na2SO4, filtered and concentrated under reduced pressure. The so obtained oily residue is then dissolved in methyl tert-butyl ether (MTBE) and the mixture is maintained under stirring for 2 hours, then cooled to 0-5°C and the so obtained solid is filtered off, washed with MTBE and dried under vacuum at 50°C till constant weight. 4.2 g of Linagliptin with a yield of 63% are obtained.
63% With sodium hydroxide In 1-methyl-pyrrolidin-2-one at 65 - 70℃; for 7h; 6 Example 6Preparation of LinagliptinThe thiocarbamate of formula (IV) (10 g, 14.3 mmols), prepared according to Example 5, is dissolved in 100 mL of N-methylpyrrolidone (NMP) and treated with a 30% NaOH solution (7.6 g, 57.0 mmols). The reaction mixture is stirred for 3 hours and then diluted with water and acidified by adding H2SO4 concentrated. The mixture is extracted with hexane and brought to pH 9.5 by adding 30% NaOH and repeatedly extracted with dichloromethane. The dichloromethane phases are collected and washed with water and then dried over Na2SO4, filtered and concentrated under reduced pressure. The so obtained oily residue is then dissolved in methyltertbutylether (MTBE) and the mixture is maintained under stirring for 2 hours, then cooled to 0-5° C. and the so obtained solid is filtered off, washed with MTBE and dried under vacuum at 50° C. till constant weight. 4.2 g of Linagliptin with a yield of 63% are obtained.
  • 5
  • [ CAS Unavailable ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
With water; sodium hydroxide In 1-methyl-pyrrolidin-2-one for 3h; 6; 8 Example 6: Preparation of Linagliptin The thiocarbamate of formula (IV) (10 g, 14,3 mmols), prepared according to Example 5, is dissolved in 100 mL of N-methylpyrrolidone (NMP) and treated with a 30% NaOH solution (7.6 g, 57.0 mmols). The reaction mixture is stirred for 3 hours and then diluted with water and acidified by adding concentrated H2SO4. The mixture is extracted with hexane and brought to pH 9.5 by adding 30% NaOH and repeatedly extracted with dichloromethane. The dichloromethane phases are collected and washed with water and then dried over Na2SO4, filtered and concentrated under reduced pressure. The so obtained oily residue is then dissolved in methyl tert-butyl ether (MTBE) and the mixture is maintained under stirring for 2 hours, then cooled to 0-5°C and the so obtained solid is filtered off, washed with MTBE and dried under vacuum at 50°C till constant weight. 4.2 g of Linagliptin with a yield of 63% are obtained.; Example 8: Preparation of Linagliptin Starting from the compound of formula (IV) as obtained in example 7 and following the procedure of example 6, product Linagliptin is obtained.
  • 6
  • [ 668270-12-0 ]
  • [ 1418133-47-7 ]
YieldReaction ConditionsOperation in experiment
25% With hydrogenchloride In water at 20℃; 1 1H-purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-1-[[4-[[2-[[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]methyl]-1,4-dihydro-4-methyl-4-quinazolinyl]methyl]-2-quinazolinyl]methyl]-7-(2-butynyl)-3,7-dihydro-3-methyl Example 1 1 H-purine-2,6-dione, 8-[(3R)-3-amino-1 -piperidinyl]-1 -[[4-[[2-[[8-[(3R)-3-amino- 1 -piperidinyl]-7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1 H-purin-1 - yl]methyl]-1 ,4-dihydro-4-methyl-4-quinazolinyl]methyl]-2-quinazolinyl]methyl]- -(2-butynyl)-3,7-dihydro-3-methyl10.0 g (21 .2 mmol) 1 H-Purine-2,6-dione, 8-[(3R)-3-amino-1 -piperidinyl]-7-(2-butyn-1 -yl)-3,7- dihydro-3-methyl-1 -[(4-methyl-2-quinazolinyl)methyl] of formula (IIA) are suspended in 30 mL aqueous hydrochloric acid (4N) and stirred over night at room temperature. Afterwards, 30 mL aqueous sodium hydroxide solution (4N) are added. The precipitate is separated and dissolved in dichloromethane. After drying of the organic phase and removal of the solvent, the remaining residue is purified by column chromatography over silica gel and the respective fractions are combined.Method: column: diameter = 8 cm, length = 25 cm; silica gel: 35 - 70 micron(DAVISIL),Eluent: CH2CI2 / MeOH / NH4OH = 90 / 10 / 0.25 (0.5 L)CH2CI2 / MeOH / NH4OH = 40 / 10 / 0.25 (0.5 L)CH2CI2 / MeOH / NH4OH = 20 / 30 / 0.25 (0.5 L)MeOH / NH4OH = 500 : 1 (1 L)TLC: silica gel 60 F254, CH2CI2 / MeOH / NH4OH = 4 / 1 / 0.1 , Rf = 0.48NH4OH stands for concentrated aqueous ammonia. The ratio of the eluent components refer to volume units.Yield: 4.95 g (25% of theory) of title compound of formula (IA)C50H56N16O4 (945.09)MS: [M+H]+ = 945
25% With hydrogenchloride In water at 20℃; 1 EXAMPLES Example 1 1H-purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-1-[[4-[[2-[[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]methyl]-1,4-dihydro-4-methyl-4-quinazolinyl]methyl]-2-quinazolinyl]methyl]-7-(2-butynyl)-3,7-dihydro-3-methyl Example 1 1H-purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-1-[[4-[[2-[[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]methyl]-1,4-dihydro-4-methyl-4-quinazolinyl]methyl]-2-quinazolinyl]methyl]-7-(2-butynyl)-3,7-dihydro-3-methyl [0157] [0158] 10.0 g (21.2 mmol) 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl] of formula (IIA) are suspended in 30 mL aqueous hydrochloric acid (4N) and stirred over night at room temperature. Afterwards, 30 mL aqueous sodium hydroxide solution (4N) are added. The precipitate is separated and dissolved in dichloromethane. After drying of the organic phase and removal of the solvent, the remaining residue is purified by column chromatography over silica gel and the respective fractions are combined. [0159] Method: column: diameter=8 cm, length=25 cm; silica gel: 35-70 micron (DAVISIL), [0160] Eluent: CH2Cl2/MeOH/NH4OH=90/10/0.25 (0.5 L) Eluent: CH2Cl2/MeOH/NH4OH=90/10/0.25 (0.5 L) [0161] CH2Cl2/MeOH/NH4OH=40/10/0.25 (0.5 L) [0162] CH2Cl2/MeOH/NH4OH=20/30/0.25 (0.5 L) [0163] MeOH/NH4OH=500:1 (1 L) [0164] TLC: silica gel 60 F254, CH2Cl2/MeOH/NH4OH=4/1/0.1, Rf=0.48 [0165] NH4OH stands for concentrated aqueous ammonia. The ratio of the eluent components refer to volume units. [0166] Yield: 4.95 g (25% of theory) of title compound of formula (IA) [0167] C50H56N16O4 (945.09) [0168] MS: [M+H]+=945
7.5% With hydrogenchloride In water at 20℃; comparative example: compound III was prepared according to the method described in WO-2013010964 10.0g 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[( 4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione(ritagliptin) was suspended in 30 mL of aqueous hydrochloric acid (4N) and stirred at room temperature overnight. add 30mL aqueous sodium hydroxide solution (4N) to separate the precipitate, and dissolve the precipitate in dichloromethane, dry, reduce steaming, and by silica gel column chromatography to obtain compound III 1.5g, yield: 7.5%, purity 97.0% (document yield 25%).
  • 7
  • 3-(R)-aminopiperidine dihydrochloride [ No CAS ]
  • [ 853029-57-9 ]
  • Linagliptin [ No CAS ]
YieldReaction ConditionsOperation in experiment
93.8% With triethyl borane; sodium carbonate; 4-methyl-2-pentanone; at 95 - 100℃; for 10h; 60.0 g (0.132 mol) of the above compound e, 22.8 g (0.132 mol) of (R)-3-aminopiperidine dihydrochloride, 42.2 g (0.398 mol) of sodium carbonate, 480 g of methyl isobutyl ketone, and 4 g of triethylborane were added in a 2L three-necked flask. The temperature was raised to 95-100C, stirring for 10h. TLC monitoring the reaction was complete (Rf (compound e) = 0.7, Rf (reaction solution) = 0.1, developing solvent: toluene / absolute ethanol = 6/1, volume ratio). Cooling to 20-30C. Dropping 10% sulfuric acid solution to adjust the system pH = 5-6. Liquid separation, the lower aqueous phase was collected. 300 g of 10% sodium hydroxide was added dropwise to the aqueous phase. Adjust the system pH = 12. A large number of solid appeared. The product was extracted twice with 400 g of * 2 methylene chloride. The organic phases were combined. Dried over anhydrous sodium sulfate. Filter desiccant. The filtrate was evaporated under reduced pressure to remove the solvent, to give linagliptin 58.5g, yield 93.8%, HPLC purity 99.9%, product ee value of 99.6%.
47% With potassium carbonate; potassium iodide; In acetic acid butyl ester; toluene; at 40 - 125℃;pH 11 - 12; To the 1500cc N-butyl acetate charged 0.55 moles Potassium carbonate, 0.01 moles Potassium iodide and 0.275 moles (3R)-piperidin-3-amine dihydrochloride and 0.22 moles <strong>[853029-57-9]8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione</strong>. Stirred the reaction mixture for 4-8hrs at 85-125C. After completion of the reaction, reaction mixture cooled to 5-10C and charged 1000cc 10% Acetic acid solution. After stirred for 10-30 min aqueous layer was washed with 300cc Methyl isobutyl ketone and 300 cc Toluene at 15-45C. Aqueous layer cooled to 5-10 C and charged 350cc 10% Sodium hydroxide. Then charged 1000cc Methylene dichloride and stirred for 20 min. aqueous layer extracted with 350cc Methylene dichloride two times. Organic layer washed with water and brine solution. Solvent distilled out completely. Charged 100cc Methanol to degassed mass and distilled out Methanol under vaccum.To the reaction mass added 2500 cc Methanol and 0.5-50% Denatured alcohol charged 0.13 mole D-tartaric acid at reflux temperature for 1 to 3 hrs. Cooled the reaction mixture at 5-15C and stirred for 2-4 hrs. Filtered the product and washed with solvent. Wet product dried at 25-45C for 4-8hrs to obtain 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl] Tartrate salt with 78-85% yield. HPLC purity: 99-99.5%. In 1500cc water, charged 1 H-Purine-2,6-dione, 8- [(3R)-3 -amino-i -piperidinylj-7-(2- butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2quinazolinyl)methyl]Tartrate salt and 2000cc Toluene at temperature of 25-55C. pH was adjusted to 11-12 with 10% Sodium hydroxide solution. Stirred for 45-75 mm and washed organic layer with water and brine solution. Distilled out the organic layer at 40-45C.To the reaction mass added 1650cc Methanol and 0.5-50% DNS charged 0.14 mole purified 1H-Purine-2,6-dione, 8-[(3R)-3-amino- 1 -piperidinyl]-7-(2-butyn-1-yl)-3,7- dihydro-3-methyl-1-[(4-methyl-2quinazolinyl) methyl] in first purification at a temperature 35-75 C. Charged 0.1 mole D-tartaric acid in 350 cc Methanol with 0.5-50% DNS at reflux temperature for 1 to 3 hrs. Cooled the reaction mixture at 5-15C and stirred for 2-4 hrs. Filtered the product and washed with solvent. Wet product dried at 25- 45C for 4-8hrs to obtain 1H-Purine-2,6-dione, 8- [(3R)-3-amino-1-piperidinyl]-7-(2- butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2quinazolinyl) methyl] Tartrate salt. In 975cc water charge 1H-Purine-2,6-dione, 8-[(3R)-3-amino- 1 -piperidinyl] -7-(2-butyn- 1- yl)-3 ,7-dihydro-3-methyl- 1 -[(4-methyl-2quinazolinyl) methyl] Tartrate salt and 1300cc Toluene at temperature 25-55C.pH adjusted 11-12 with 10% Sodium hydroxide solution. Stirred for 45-75 mm and washed organic layer with water and brine solution. Distilled out solvent at 40-45C. Charged DNS at a temperature 45-85C and stirred for 30 mm. cooled the mixture at 15-35 C and filtered to obtain pure 1H-Purine-2,6-dione, 8-[(3R)- 3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl] with 47% yield. HPLC purity: 99-99.95%
17.6 g With potassium carbonate; at 30 - 95℃; for 8h; 1 -[(4-Methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1 -yl)-8-bromoxanthine (20 gm) and methyl isobutyl ketone (MIBK 200 ml_) were charged into a 1000 ml_ round bottomed flask equipped with a mechanical stirrer. Potassium carbonate (18.3 gm) and (R)-piperidine-3-amine dihydrochloride (1 1 .5 gm) were added to the reaction mixture at 30C. The reaction mixture was heated to 95C and maintained at that temperature for 8 hours. The reaction mixture was cooled to 30C and filtered and washed with MIBK (40 ml_). The filtrate was charged into another flask and added 10% aqueous acetic acid solution and stirred for one hour at room temperature. The aqueous layer was separated and washed with 60 ml_ of dichloromethane. The aqueous layer was charged into another flask and 200 ml_ of dichloromethane and 100 ml_ of aqueous sodium hydroxide solution was added drop-wise at 30 C. The mixture was stirred for one hour at 30 C and the organic layer was separated and the aqueous layer was extracted with 100 ml of dichloromethane. Combined the organic layers and evaporated under vacuum at below 45C. Isopropyl alcohol (100 mL) was added to the residue and stirred for 3 hours at room temperature. Filtered the compound and washed with isopropyl alcohol (20 mL) and dried the compound at below 60 C under vacuum to give 17.6 gm of Linagliptin. PXRD pattern: Fig. 2, Purity: 99.0%
100 mg With caesium carbonate; In N,N-dimethyl-formamide; at 20 - 120℃; for 12h; Example 1 : Preparation of linagliptin 2-Bromo- 1 -(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-y l)methyl)- 1 H- imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione (100 gm) was dissolved in dimethylformamide (500 ml) and then added cesium carbonate (180 gm) and (R)-(-)-3- aminopiperidine dihydrochloride (42 gm) at room temperature. The reaction mixture was heated to 120C and maintained for 12 hours. The reaction mass was then cooled to room temperature and then added water (1000 ml) and dichloromethane (2000 ml). The layers were separated and the aqueous layer was extracted with dichloromethane. Combined organic layers were dried with sodium sulfate and then concentrated to provide 100 gm of linagliptin
2.5 g With benzyltrimethylammonium chloride; sodium hydroxide; In Isopropyl acetate; water; for 24h;Reflux; A solution of 1 - [(4-methylquinazolin-2-yl) methyl] -3-methyl-7- (2-butyn-1-yl) -8-bromoxanthine 0.006 mol),(R) -3-aminopiperidine dihydrochloride (Compound II, 1.7 g, 0.01 mol)Sodium hydroxide (1.2 g, 0.03 mol), benzyltrimethylammonium chloride (PTC, 0.56 g, 0.003 mol)Water (10 ml) and isopropyl acetate (40 ml) were added to the reaction flask and heated to reflux for 24 hours.After cooling to room temperature, 20 ml of water was added and the organic layer was collected after stirring. The aqueous phase was washed with isopropyl acetate and the organic phases were combined and concentrated to give 1 - [(4-methylquinazolin-2-yl) Methyl-7- (2-butyn-1-yl) -8- (3- (R) -aminopiperidin-1-yl) -oxanthine (Compound 2). Yield: 2.5 g (90% of theory).

  • 8
  • [ 1801659-12-0 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
35.4 g With water; sodium hydroxide In toluene at 45℃; for 1h; 16.b (b) Isolation of pure Linagliptin Linagliptin-D-(-)-tartrate (45 gm), water (675 mL) and toluene (900 mL) were charged into 5000 mL round bottomed flask and stirred for 10 minutes at 28°C. The resulted solution was heated to 45 °C and 45 mL of 9% aqueous sodium hydroxide solution was added to the mixture at 45°C (pH is 1 1 .30) and maintained for 1 hour. Layers were separated and organic layer was washed with water (225 mL X 2). Combined the organic layers and distilled off the organic layer under vacuum at 45 °C to give 35.4 gm of linagliptin. Chemical Purity: 99.86%, Chiral purity: 99.97%, (S)-isomer content: 0.03%, Regio impurity: 0.08%, Bromo impurity: 0.05%.
  • 9
  • [ 668270-12-0 ]
  • [ 1233245-24-3 ]
YieldReaction ConditionsOperation in experiment
75.25% With phosphoric acid In ethanol at 20℃; for 6h; 1 Example 1 : Preparation of Linagliptin Phosphate Ethanol (400 mL) was added to a reaction vessel containing linagliptin (40 g) at ambient temperature. The reaction mixture was heated to about 45°C, stirred for about 15 minutes, and then cooled to ambient temperature. Ortho-phosphoric acid (9.8 g; about 85% solution) was added to the reaction mixture. The reaction mixture was stirred at ambient temperature for about 6 hours, filtered, washed with ethanol (2 x 50 mL), and dried at about 45°C under reduced pressure for about 12 hours to obtain crude linagliptin phosphate (HPLC purity: 98.88%). Iso-propanol (500 mL) was added to crude linagliptin phosphate (47.5 g) at ambient temperature. The reaction mixture was heated to about 78°C. Water (220 mL) was added slowly into the reaction mixture. Activated carbon (2.5 g) was added. The reaction mixture was stirred for about 15 minutes, and then filtered through a celite bed. The celite bed was washed with 30% solution of water and iso-propanol (1 x 50 mL). The contents were slowly cooled to ambient temperature, stirred for about 4 hours and 30 minutes, filtered, washed with iso-propanol (2 x 50 mL), and dried at about 44°C for about 10 hours under reduced pressure to obtain the pure linagliptin phosphate. Yield: 75.25% HPLC Purity: 99.72%
  • 10
  • [ 1233245-24-3 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
91.9% With sodium hydrogencarbonate In water at 3 - 45℃; for 3h; 2 Example 2: Preparation of the Stable Amorphous Form of Linagliptin Sodium bicarbonate (4.8 g) was added to a reaction vessel containing linagliptin phosphate (6.5 g) in water (87 mL) at about 3°C to about 5°C. The reaction mixture was heated to about 40°C to about 45°C, and stirred for about 3 hours. The reaction mixture was cooled to about 3°C to about 5°C, stirred for about 1 hour, filtered, washed with water (19.5 mL), and dried at about 85°C to about 90°C for about 12 hours to obtain the stable amorphous form of linagliptin. Yield: 91.9%
  • 11
  • [ 1573118-33-8 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
With ethanolamine In toluene at 100 - 110℃; for 3h; 6 Preparation of Linagliptin In a RBF 1 ml of toluene, 100 mg of 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-4-methylphthalimidopiperidin-1-yl)-xanthine, 0.1 ml of ethanolamine were charged, the temperature was raised to about 100-110° C. and the reaction mass was maintained for about 3 hours to complete the reaction. After the completion of the reaction, the reaction mass was cooled to about 80° C. The aqueous and oil layers were separated. The aqueous layer was extracted again with 1 ml of toluene. The organic layers were combined and washed with 2 ml of water at about 80° C. The organic layer was concentrated under vacuum to get an oily mass. Added 2 ml water to the oily mass and adjusted the pH to about 2-3 using aq. HCl. The aqueous layer was washed with methylene dichloride (MDC). The pH of aqueous layer was adjusted to about 10-12 using 5% aq NaOH solution. The product was extracted in MDC and worked up by either of the methods (a), (b) or (c) listed below
  • 12
  • [ 1573118-30-5 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
With water; sodium hydroxide In dichloromethane at 20℃; for 0.5h; 24 Preparation of Linagliptin In a clean round bottom flask, 10 gm of Linagliptin dibenzoyl-D-tartaric acid salt and 100 ml methylene dichloride were charged. 100 ml water was added and pH was adjusted to 8-10 by adding 5% Aq. NaOH. The reaction mass was stirred at room temperature for 30 min. and the layers were separated. The organic layer was distilled under vacuum and pure linagliptin was isolated from a 120 ml mixture of methylene dichloride and methyl tert butyl ether. Dry Wt: 5.50 gm HPLC purity: 99.64%, Impurity X: 0.06% Chiral Purity: Unwanted isomer: 8-[3(S)-Aminopiperidin-1-yl]-7-(2-butynyl)-3-methyl-1-(4-methylquinazolin-2-ylmethyl)xanthine, NMT 0.02%
  • 13
  • [ 668270-12-0 ]
  • [ 1621617-40-0 ]
  • [ 1621617-42-2 ]
YieldReaction ConditionsOperation in experiment
With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃; General procedure: To a solution of 3 (2.7 g, 5.0 mmol) in 1,4-dioxane and waterwas added sodium hydroxide (0.40 g, 10 mmol) and the reactionmixture was stirred at ambient temperature for 3 h. Thereaction was evaporated to dryness, and the residue was dissolvedin water. The pH of the solution was adjusted to 3 with2 mol/L HCl. The formed precipitate was filtered, washedwith cold water, and dried under vacuum to yield the titlecompound
  • 14
  • [ 668270-12-0 ]
  • [ 88-95-9 ]
  • [ 886588-63-2 ]
  • [ 2074688-82-5 ]
  • [ 2074688-83-6 ]
YieldReaction ConditionsOperation in experiment
1: 3.5 g 2: 12% 3: 11% With triethylamine In dichloromethane for 24h; N,N-bis((R)-1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide (4) Phthaloyl dichloride (1.0 g, 0.005 mol) was added slowly toa stirred solution of 1 (4.8 g, 0.010 mol) and triethylamine (5.0 g, 0.05 mol) in CH2Cl2 (50.0 mL) at rtand refluxed for 24 h. Then the mixture was cooled to rt and 1 mol/L aq. NaOH (30 mL) was added,and maintained for 2 h. The isolated solid was collected by filtration and washed with water (20.0 mL),CH2Cl2 (20.0 mL) and methanol (20.0 mL). Then dried to yield 4 as a light yellow solid (3.5 g, 66.1%)
  • 15
  • [ 334618-23-4 ]
  • [ 1979144-52-9 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
77% With sodium hydrogencarbonate In 1-methyl-pyrrolidin-2-one at 90℃; for 2h; 4 Example 4: Preparation of Linagliptin A total of 10.0 g of 7-but-2-ynyl-8-chloro-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine- 2,6-dione (12), 5.1 g of (R)-3-aminopiperidine dihydrochloride (13), 30 mL of NMP and 7.2 g of sodium bicarbonate was added into a 250 mL three-necked round-bottomed flask. The reaction mixture was heated to 90°C and stirred for 2 h, then cooled down to 40 °C. Then, a total of 90 mL of dichloromethane (DCM) and 90 mL of water were charged, and the reaction mixture was stirred for 25 mm. The organic phase was collected and the aqueous phase was extracted with another 30 mL of DCM. The combined organic phase was washed with 90 mL of H20 for 3 times (each washing takes no less than 20 mm) and then stirred with 122.9 g of acetic acid solution (2.4 wt% in water) for 30 mm. To the collected aqueous phase was charged with 120 mL of DCM and 49 mL of 1 N aq. NaCH solution. The resulting mixture was stirred for 30 mm. The organic phase was collected and concentrated to dryness. The resulting yellow crude product was suspended in 30 mL of toluene and heated to reflux and stirred for 1 h. Then it was cooled down to 70 °C and stirred for 1 h. Next, it was cooled down to 50 °C slowly and stirred for 1 h. Finally, it was cooled down to 25 °C slowly and stirred for 2 h. The product was collected by filtration and dried under vacuum. A total of 8.9 g (yield 77%) of Linagliptin was obtained as pale yellow solid with 99.2% HPLC purity. ‘H NMR (500 MHz, DMSC-d6): ö 8.22 (d, 1H, i = 8.0 Hz), 7.89 (m, 1H), 7.80 (d, 1H, i = 8.5 Hz), 7.68 (m, 1H), 5.32 (s, 2H), 4.90 (s, 2H), 3.59-3.67 (m, 2H), 3.00 (m, 1H), 2.88 (s, 3H), 2.81-2.85 (m, 1H), 2.74-2.78 (m, 1H), 1.78-1.88 (m, 5H), 1.59-1.66 (m, 3H), 1.20-1.27 (m, 1H); ‘3C NMR (125 MHz, DMSC-d6): ö 168.78, 160.97, 156.11, 153.20,150.90, 149.01, 147.71, 134.01, 127.83, 127.08, 125.67, 122.45, 103.17, 81.10, 73.74, 57.61, 49.54, 47.27,45.53, 35.47, 33.23, 29.39, 23.28, 21.53, 3.05; Mass (m/z): 473.2 (M+H).
  • 16
  • [ 334618-23-4 ]
  • [ 2056029-11-7 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
54% In dimethyl sulfoxide at 110℃; for 4h; 8 Example 8: Preparation of Linagliptin A total of 5.0 g of 7-but-2-ynyl-8-iodo-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6- dione (17), 1.9 g of (R)-3-aminopiperidine dihydrochloride (13), 15 mL of DMSO and 2.77 g of NaHCO3 was charged into a three-necked roud-bottomed flask. The mixture was heated to 110 °C and stirred for 4 h, then cooled down to 40 °C. A total of 45 mL of water was added, followed by addition of 45 mL of dichloromethane. The mixture was stirred for 15 mm. The organic phase was collected and the aqueous phase was extracted with 30 mL of dichloromethane. The combined organic phases was washed with 20 mL of water, then concentrated to dryness. The crude product was purified by column chromatography. A total of 2.53 g (yield 54%) of Linagliptin was obtained as pale yellow solid with 99.0% purity. ‘H NMR (500 MHz, DMSO-d6): ö 8.22 (d, 1H, i = 8.0 Hz), 7.89 (m, 1H), 7.80 (d, 1H, i = 8.5 Hz), 7.68 (m, 1H), 5.32 (s, 2H), 4.90 (s, 2H), 3.59-3.67 (m, 2H), 3.00 (m, 1H), 2.88 (s,3H), 2.81-2.85 (m, 1H), 2.74-2.78 (m, 1H), 1.78-1.88 (m, 5H),1.59-1.66 (m, 3H), 1.20-1.27 (m, 1H); ‘3C NMR (125 MHz, DMSO-d6): ö 168.78, 160.97, 156.11, 153.20,150.90, 149.01, 147.71, 134.01, 127.83, 127.08, 125.67, 122.45, 103.17, 81.10, 73.74, 57.61, 49.54, 47.27,45.53, 35.47, 33.23, 29.39, 23.28, 21.53, 3.05; Mass (m/z): 473.2 (M+H).
  • 17
  • [ 668270-12-0 ]
  • [ 15761-38-3 ]
  • [ 1620832-91-8 ]
YieldReaction ConditionsOperation in experiment
93.9% With potassium carbonate; benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane at 20℃; 3.1 The first step is the synthesis of compound 3a Using a known method, Compound 1a (500mg, 1.06mmol) was dissolved in DCM (10ml) was added DCC (262mg, 1.27mmol), HOBT (144mg, 1.06mmol), K 2CO3(220mg, 1.59mmol), N-Boc-L- alanine (200mg, 1.06mmol), at room temperature overnight. The reaction was followed by thin layer chromatography, it shows complete consumption of starting material. Filtered off with suction, the filter cake is washed with an appropriate amount of DCM, and the filtrate was concentrated to dryness to give the product compound 3a (640mg, yellow solid), yield 93.9%.
  • 18
  • [ 4530-20-5 ]
  • [ 668270-12-0 ]
  • [ 1620832-92-9 ]
YieldReaction ConditionsOperation in experiment
95.5% With potassium carbonate; benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane at 20℃; 4.1 The first step is the synthesis of compound 4a Using a known method, Compound 1a (500mg, 1.06mmol) was dissolved in DCM (10ml) was added DCC (262mg, 1.27mmol), HOBT (144mg, 1.06mmol), K2CO3(220mg, 1.59mmol), N-Boc- glycine (185mg, 1.06mmol), at room temperature overnight. The reaction was followed by thin layer chromatography, it shows complete consumption of starting material. Filtered, the filter cake washed with an appropriate amount of DCM, and the filtrate was concentrated to dryness to give the product compound 4a (636mg, yellow solid), yield: 95.5%.
  • 19
  • [ 668270-12-0 ]
  • [ 124-63-0 ]
  • [ 1620832-93-0 ]
YieldReaction ConditionsOperation in experiment
88.8% With triethylamine In dichloromethane at 20℃; 1.1 The first step in the synthesis of compound 1 Using a known method, Compound 1a (200mg, 0.42mmol) was dissolved in DCM (5ml) was added triethylamine (100mg, 0.99mmol), stirring was added dropwise methanesulfonyl chloride (58mg, 0.51mmol), dropwise at room temperature the reaction overnight, the reaction was followed by thin layer chromatography, show complete consumption of starting material, the reaction was washed with saturated brine, dried, and concentrated under reduced pressure, the residue was purified by preparative thin layer chromatography (DCM: MeOH = 20: 1) to give the product compound 1 (207mg, yellow solid), yield: 88.8%.
  • 20
  • [ 668270-12-0 ]
  • [ 814-49-3 ]
  • [ 1620832-94-1 ]
YieldReaction ConditionsOperation in experiment
74.1% With triethylamine In dichloromethane at 0 - 20℃; 2.1 Step 1 Synthesis of Compound 2 Using a known method, Compound 1a (213mg, 0.45mmol) was dissolved in DCM (5ml) was added triethylamine (90mg, 0.9mmol), cooled to about 0 deg.] C with stirring, diethyl chlorophosphate was added dropwise in DCM (85ml, 0.49mmol, 1ml DCM), dropwise naturally warm to room temperature overnight. The reaction was followed by thin layer chromatography, it shows complete consumption of starting material. The reaction was washed twice with saturated brine solution with liquid separation, and the organic phase was concentrated to dryness, the residue was purified by preparative thin layer chromatography (DCM: 1: MeOH = 10) to give the product compound 2 (203mg, yellow solid), yield : 74.1%
  • 21
  • [ 856408-24-7 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
88.5% With acetic acid In water at 75℃; 29 Embodiment 29 advantage Ralli sandbank (I) synthesis of For 100 ml three-mouth bottle point pen (V) compound (by the embodiment 25 prepared to) 4.88g (10mmol), 80 ml glacial acetic acid, 16 ml water, raising the temperature to 75 °C; adding reducing iron powder 0.84g (15mmol), to maintain the 75 °C stirring, HPLC (%) monitoring the reaction is complete; cooling to 20 °C, filtering, washing; reduced pressure distillation, to remove the solvent, then adding 215 ml water, then 20% NaOH to adjust the pH=9.0; separating solid, filtering, washing, dichloromethane - methyl tert-butyl ether recrystallization, vacuum drying, get 4.18g white solid lillah row sandbank. Molar yield 88.5%.
  • 22
  • [ 1673546-65-0 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
0.23 g With caesium carbonate; sodium hydroxide In ethanol for 24h; Reflux; 20-D A solution of 1 - [(4-methylquinazolin-2-yl) methyl] -3-methyl-7- (2-butyn-1-yl)(3- (R) -benzoylaminopiperidin-1-yl) -oxanthine (Compound III-2, 0.57 g, 1 mmol)Cesium carbonate (0.65 g, 2 mmol) and sodium hydroxide (0.04 g, 1 mmol) were added to 20 ml of ethanol and the reaction was heated under reflux for 24 hours. The filtrate was collected by filtration, and the residue was concentrated.The residue was added to 20 ml of dichloromethane, and the dichloromethane layer was washed with 15 ml of water, and the organic layer was collected. (3-methyl-2-yl) methyl] -3-methyl-7- (2-butyn-1-yl) -8- (3- (R) -amino Piperidin-1-yl) -oxanthine (Compound 2). Yield: 0.23 g (50% of theory).
  • 23
  • [ 1673546-68-3 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
0.3 g With ethanolamine In toluene at 80 - 85℃; for 8h; 20-B A solution of 1 - [(4-methylquinazolin-2-yl) methyl] -3-methyl-7- (2-butyn-1-yl) -8- (3- (R) - (2,5-dioxotetrahydropyrrole-1-yl) piperidin-1-yl) -oxanthine (Compound III-3, 0.5 g, 1 mmol)Ethanolamine (0.6 g, 1 mmol) and toluene (5 ml) were added to the reaction flask and heated to 80-85 ° C for 8 hours.The reaction mixture was washed twice with hot water at 80 ° C, and the toluene solution was collected. The residue after toluene concentration was heated and refluxed with ethanol, dissolved and slowly cooled to room temperature to 25 ° C,After the solid was precipitated, methyl tert-butyl ether was added and stirring was continued for 2 hours. The suspension was cooled to below 5 ° C and stirring was continued for 2 hours,(2-butyn-1-yl) -8- (3- (4-methylquinazolin-2-yl) methyl] -3-methyl- R) -aminopiperidin-1-yl) -oxanthine (Compound 2).Yield: 0.3 g (70% of theory)Chemical purity: 99.68%; impurity 1,0.02%; impurities 2,0.01%; other single impurities are less than 0.1%.Optical purity: 99.9%.
  • 24
  • [ 1673546-71-8 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
0.25 g With ethanolamine In toluene at 75 - 85℃; for 6h; 20-C A solution of 1 - [(4-methylquinazolin-2-yl) methyl] -3-methyl-7- (2-butyn-1-yl)(3- (R) - (1,3-dioxo-1H-hexahydroindol-2 (3H) -yl) piperidin-1-yl) -oxanthine (Compound III-4,0.6 g, 1 mmol) was heated to 18 ml of toluene80-85 ° C. Subsequently,Ethanolamine (3 g, 5 mmol) was added to the mixture at 75-80 ° C.The mixture was stirred at 80-85 ° C for 6 hours to complete the reaction.The mixture was washed twice with 10 ml of hot water at 80 ° C, and the toluene solution was collected,(3-methyl-2-yl) methyl] -3-methyl-7- (2-butyn-1-yl) -8- (3- (R) -amino Piperidin-1-yl) -oxanthine (Compound 2).Yield: 0.25 g (55% of theory) Chemical purity: 99.57%; impurity 1,0.02%; impurity 2,0.02%; other individual impurities less than 0.1%. Optical purity: 99.9%
  • 25
  • [ 668270-12-0 ]
  • [ 1621617-29-5 ]
  • [ 1621617-30-8 ]
YieldReaction ConditionsOperation in experiment
70% With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃; 89 (R, E) -N- {1_ {3-Methyl-7- (but-2-ynyl) -l_ [(4-methylquinazolin-2- yl) methyl] Dioxo-2,3,6,7-tetrahydro-lH-purine-8-yl} -nicotin-3- yl} -1- {3- {3- methyl-5- [3- (4- Cyclopropyl-1,2,3,4-tetrahydroquinoxaline-1-carbonyl) pyridin-4-oxy] -6-chloro- benzofuran-2-yl} -N-methylacrylamide } -3,6,9,12,15,18-hexaoxa dioxane dioxane 21-amide E-1- {3-methyl-5- [3- (4-cyclopropyl, 2,3,4-tetrahydroquinoxaline-1-carbonyl) Yl] -6-chlorobenzofuran-2-yl} -4-methyl-3-oxo-7,10,13,16,19,22-hexaoxa-4-aza-1-25-carboxylic acid (196 mg, 0.22 mmol) was dissolved in dichloromethane and linagliptin was added (105 mg, 0.22 mmol), triethylamine (53 μl, 0.44 mmol) and HATU (130 mg, 0.33 mmol ) Overnight at room temperature, the reaction was evaporated to dryness, the product was purified by preparative HPLC 205mg, the yield was 70%
  • 26
  • 8-[(R)-3-aminopiperidin-1-yl]-3,7-dihydro-3-methyl-7-(2-butynyl)-1H-purine-2,6-dione [ No CAS ]
  • [ 109113-72-6 ]
  • Linagliptin [ No CAS ]
YieldReaction ConditionsOperation in experiment
94.8% With potassium carbonate; In N,N-dimethyl-formamide; at 80℃; for 10h; The compound 8-[(R)-3-amino-piperidin-1-yl]-3,7-dihydro-3-methyl-7-(2-butynyl)-1H-indole-2,6 -dione 100 mmol,4-methyl-2-chloro-methylquinazoline150mmol and 160mmol of potassium carbonate and 200ml of N,N-dimethylformamide were added to the reactor and stirred.The temperature was raised to 80 C for 10 hours, after the reaction was completed,Cool down, add 1200ml water, precipitate solids, filter,The obtained solid was added to 500 ml of dichloromethane and 500 ml of water, and the layers were stirred.The organic layer was evaporated to dryness, and 400 mL of ethanol was added to the residue.The temperature was raised to 70-75 C, and the solid was completely dissolved and kept for 0.5 h.Then slowly cool to room temperature and crystallize, after stirring at room temperature for 4 h,Add 300 mL of methyl tert-butyl ether and cool to 5 C.Stir for 2 hours with heat. Filter and filter the cake with 100 mL of methyl tert-butyl ether.Drying gave linagliptin in a yield of 94.8% and a purity of 99.9%.
1.8 g With sodium hydrogencarbonate; In 1-methyl-pyrrolidin-2-one; at 90℃; 1 g of compound e,1.8 g of compound d and 0.7 g of sodium bicarbonate were added to 10 mL of N-methylpyrrolidone,Stirring heated to 90 reaction,TLC monitoring, the reaction is complete,Cooling to 20 ,The reaction mixture was poured into 50mL of water,Precipitation of the solid,filter,The resulting solid was added to 20 mL of methylene chloride and 20 mL of water,Stirring 1h, liquid separation,The organic layer was evaporated to dryness to give linagliptin, which had a mass of 1.8 g;
  • 27
  • [ 1519905-45-3 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
96.1% With ethanol; 10% Pd/C at 20℃; 9-1.b Step b obtained in the step a product, 10% of palladium-carbon (40g), ethanol, stirring at room temperature to the reaction is complete, filtering, the filtrate is concentrated and dried, crude methanol recrystallization, profit ralli sandbank 107.8g, yield 96.1%, ee
  • 28
  • [ CAS Unavailable ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
92% With diethylamine In tetrahydrofuran for 2h; Reflux; 9-2.b Step b obtained in the step a product and ethylenediamine (40g) mixing, in tetrahydrofuran (300 ml) in, heating to flow back to the reaction is complete (about 2 hours), water treatment, chloroform extraction, anhydrous sodium sulfate drying, evaporate the solvent, the crude product is recrystallized with methanol, profit ralli sandbank 102g yield 92.0%, ee value _AOMARKENCODEGTX0AO _ 99%, HPLC purity 99.8%.
  • 29
  • [ 1519905-51-1 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
96% Stage #1: C41H36N8O4 With hydroxylamine hydrochloride; triethylamine In ethanol; water Inert atmosphere; Reflux; Stage #2: With sodium hydroxide at 20℃; for 24h; Cooling with ice; 9-4.b Step b under the protection of nitrogen product of step a, hydroxylamine hydrochloride (247g) and triethylamine (346 ml) is mixed solution of ethanol and water (800 ml: 200 ml) in, heating reflux only the reaction is complete. Keep the nitrogen protection, in the reaction solution in the ice bath cooling, slowly adding sodium hydroxide (200g), stirring at room temperature 24 hours, filtering, the filtrate is concentrated, the crude product is recrystallized with methanol, profit ralli sandbank 104.2g (yield 96%), the value of the ee _AOMARKENCODEGTX0AO _ 99%, HPLC purity 99.8%.
  • 30
  • [ 1519905-53-3 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
94% With sodium tetrahydroborate In chloroform for 0.25h; 9-5.b Step b prepared in the step a of the compound is dissolved into chloroform (500 ml), gradually adding sodium borohydride (40g), stirring until the reaction is complete (about 15min). The water is added after completion of the reaction, filtration, collection of the organic layer, concentrated, methanol is recrystallized, profit ralli sandbank 104g (yield 94%), ee value _AOMARKENCODEGTX0AO _ 99%, HPLC purity 99.8%.
  • 31
  • [ 1519905-60-2 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
94% With acetic acid In tetrahydrofuran; water at 20℃; 9-7.b Step b the product of step a in tetrahydrofuran soluble, adding acetic acid aqueous solution, stirring at the room temperature until the reaction is complete, concentrated, filtration, recrystallization with methanol, to obtain 106g (yield 94%), ee value _AOMARKENCODEGTX0AO _ 99%, HPLC purity 99.8%.
  • 32
  • [ 668270-12-0 ]
  • [ 1135-24-6 ]
  • [ 2166116-58-9 ]
YieldReaction ConditionsOperation in experiment
85% In methanol for 1h; Reflux; 1 [Example 1] Synthesis of linagliptin ferulinate salt Korean Patent Registration No. 1150449 Example 2 A preparation concentrate20.0 g of linagliptin is dissolved in 400.0 ml of methanol and 1 mol equivalent of ferulic acid is added. When precipitation is observed, reflux is stirred for 1 hour, heating is stopped, the solution is gradually cooled, and the suspension is stirred at room temperature for 1 day. The suspension was cooled to 0 to 5 DEG C and stirred for 1 hour. After suction filtration, the crystals were washed with methanol and dried at 25 DEG C under vacuum to obtain 24.0 g of linalogliptin ferulic acid salt. (Yield: 85%, purity: 99.63%)
  • 33
  • [ 668270-12-0 ]
  • [ 38075-11-5 ]
  • [ 62062-65-1 ]
  • [ 2281000-78-8 ]
YieldReaction ConditionsOperation in experiment
65.21% Stage #1: Linagliptin; (methoxymethyl)phosphonoyl dichloride With triethylamine In dichloromethane at -10 - -5℃; for 1h; Inert atmosphere; Stage #2: alanine isopropyl ester hydrochloride With triethylamine In dichloromethane at 20℃; for 3h; Inert atmosphere; 4 isopropyl (2S)-2-[[[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)) -2,6-dioxoindole-8-yl]-3-piperidinyl]amino]-(methoxymethyl)phosphoryl]amino]propionate dichloromethane (10 mL) was added to the reaction flask under nitrogen, and (methoxymethyl)phosphorus dichloride (1B) (0.34 g, 2.1 mmol) was added with stirring, and cooled to -10 ° C to -5 ° C. . A mixed solution of linagliptin (4A) (0.94 g, 2 mmol), triethylamine (0.20 g, 2 mmol) and dichloromethane (5 mL) was slowly added dropwise, and the mixture was reacted at -10 ° C to -5 ° C for 1 h after the addition.Then a solution of L-alanine isopropyl ester hydrochloride (1C) (0.35 g, 2.1 mmol) in dichloromethane (5 mL) and triethylamine (0.43 g, 4.2 mmol) After 3 h of reaction, dichloromethane (30 mL) and water (50 mL) were added and stirred for 5 min.Let stand layering. The organic layer was dried over anhydrous sodium sulfate (MgSO4). 2S)-2-[[[(3R)-1-[7-but-2-ynyl-3-methyl-1[(4-methylquinazolin-2-yl)methyl]-2, 6-dioxoindole-8-yl]-3-piperidinyl]amino]-(methoxymethyl)phosphoryl]amino]propionate (compound 4), yellow white foamy solid 0.92 g,Yield: 65.21%.
  • 34
  • [ 668270-12-0 ]
  • [ 537-98-4 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
85% In methanol for 1h; Reflux; Preparation of Linagliptin-Ferulic Acid Cocrystal. Linagliptin base (1.00 g, 2.1 mmol) was dissolved in20 mL of MeOH, and then ferulic acid (0.41 g, 2.1 mmol)was added with stirring. The solution was refluxed for 1 h,then gradually cooled and stirred at room temperature for20 h and then cooled down to 0-5 C. The resulting precipitatewas filtered and dried in vacuo to give a pale yellowwhite solid (1.20 g, 85% yield).(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4 methylquinazolin-2-yl)-methyl)-1H-purine-2,6(3H, 7H)-dione Ferulic acid (Linagliptin-FerulicAcid). 1H NMR (DMSO-d6, 400 MHz) δ (ppm): 8.24 (d,J = 8.0 Hz,1H), 7.90 (td, J = 8.0, 1.2 Hz, 1H), 7.80 (d,J = 8.4 Hz, 1H), 8.4 Hz, 1H), 6.34 (d, J = 16.0 Hz, 1H),5.31 (s, 2H), 4.90 (m, 7.67 (td, J = 8.0 Hz, 1H), 7.41 (d,J = 15.6 Hz, 1H), 7.23 (d, J = 1.6 Hz, 1H), 7.03 (dd,J = 8.4, 2.0 Hz, 1H), 6.77 (d, J = 8.4 Hz, 1H), 6.34 (d,J = 16.0 Hz, 1H), 5.31 (s, 2H), 4.90 (m, 2H), 3.80 (s, 3H),3.67 (m, 1H), 3.58 (m, 1H), 3.39 (s, 3H), 3.03 (m, 1H),2.93 (m, 1H), 2.88 (s, 3H), 2.84 (m, 1H), 1.89 (m, 1H),1.80 (m, 1H), 1.77 (s, 3H), 1.64 (m, 1H), 1.31 (m, 1H).FT-IR (cm-1): 3200, 2953, 1705, 1661, 1608, 1574, 1517,1435, 1366, 1263, 1125, 952, 753. MS m/z: 473.2[M + H]+, 193.0 [M-H]-.
  • 35
  • [ CAS Unavailable ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
89.9% With hydroxylamine In ethanol; water; toluene at 20 - 25℃; for 2h; 9-17 Synthesis of Linagliptin 40 g (71 mmol) of (V) (R = H, Rt = Ph) obtained as in example 8, are charged into a 1 L flask, with 160 ml of toluene and 40 ml of ethanol, under inert atmosphere. 6.6 ml (107 mmol) of a 50% aqueous hydroxylamine solution are slowly added at 20-25°C and the mixture is kept under stirring, at the same temperature, for 2h. The organic phase is washed with 200 ml of water, then cooled to l5°C and 240 ml of water and 5.7 ml of glacial acetic acid are added (up to a pH of about 4.5). After phase separation, the aqueous phase, maintaining the temperature at l5°C, is extracted with 200 ml of toluene. Then 200 ml of toluene and 18.9 ml of an aqueous solution of 30% ammonium hydroxide are added to the aqueous phase (up to a pH of about 9.5). The biphasic mixture is heated to 60°C and after separation of the aqueous phase, the organic phase is concentrated under vacuum. The obtained suspension is cooled to 20-25°C, 160 ml of methyl-t-butyl ether are added and the mixture is heated to 60°C. The mixture is kept under stirring at 60°C for 2 hours, then cooled to 20-25°C. The solid is filtered, washed with 80 ml of methyl-t-butyl ether at 20-25°C and dried under vacuum at 60°C for 16 hours to obtain 30 g of Linagliptin (I) (yield 89.9%) , having chemical purity > 99.5% from HPLC analysis, regioisomer content (IV) lower than 0.04% and allenes content lower than 0.05%.
  • 36
  • [ 2387664-66-4 ]
  • [ 668270-12-0 ]
YieldReaction ConditionsOperation in experiment
80% With sodium hydroxide In dichloromethane; water at 20℃; for 0.5h; 3 Example 3- Synthesis of Linagliptin from Linagliptin Picolinate Salt 13 g of purified linagliptin picolinate salt (hereinafter referred to as Refine LGT Picolinate in Scheme 3), 130 ml of H 2 O, 130 ml of MC, and 10.4 g of NaOH were added thereto and stirred at room temperature for 30 minutes. After stirring, the layers were separated to obtain an organic layer. 65 ml of H 2 O was injected into the separated organic layer and stirred at room temperature for 30 minutes. The layers are separated to take an organic layer. The organic layer was concentrated under reduced pressure, 65 ml of EtOH was added to the concentrated residue, and cooled to 0 ° C., and 130 ml of H 2 O was injected. 5 hours, after stirring at 0 dehydrated. The dehydrated solid is washed twice with 13 ml of H 2 O. 8.25 g of linagliptin (hereinafter referred to as Linagliptin) was obtained through nitrogen drying and vacuum drying after washing. (Yield 80%, Purity 99.93%)
Same Skeleton Products
Historical Records